2017 (2) TMI 830

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... Per: Ramesh Nair The appellants are engaged in the manufacture of medicaments falling under Chapter heading 30.03. Certain medicaments viz. Di-carb-100, Dicarb-150, Quininga tablets, quininga injection, dobinga injection, Logout tablets, Logout SR, Cygest 100, Cygest 200 are exempted from payment of duty under notification no. 6/2002-CE dated 01.03.2002. 2. The appellant availed credit on some .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... d penalty of equivalent amount. However, rest of the demand of penalty was set aside. Being aggrieved by the impugned order the appellant is before me. 3. Shri Sachin Chitnis, ld. counsel for the appellant submits that it is wrong to say that the appellant have not been maintaining separate account. It is admitted fact that product being medicaments each and every batch record is maintained in th .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... of the impugned order. 5. I have carefully considered the submissions made by both sides. I find that there is no dispute that the appellant have suo moto reversed the cenvat credit attributable to the common inputs used in the manufacture of exempted goods. As regards the maintenance of separate records, it is admitted fact that the product being a medicament, it is a statutory requirement to m .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X